Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5‐ and BA.5‐XBB‐convalescent subpopulations

Documenti analoghi

• Complement Hyperactivation Is Mediated by Alternative and Lectin Pathways During Early Phase of Severe Vaccination‐Omicron BA.5 Infection
  di: Jinpeng Cao, et al.
  Pubblicazione: (2026)
• Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity
  di: Mingzhu Huang, et al.
  Pubblicazione: (2024)
• Differential pathogenic and molecular features in neurological infection of SARS‐CoV‐2 Omicron BA.5.2 and BA.2.75 and Delta
  di: Erlin Wang, et al.
  Pubblicazione: (2024)
• Neutralizing antibody response to SARS‐CoV‐2 bivalent mRNA vaccine in SIV‐infected rhesus macaques: Enhanced immunity to XBB subvariants by two‐dose vaccination
  di: Julia N. Faraone, et al.
  Pubblicazione: (2024)
• JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV
  di: Giulia Matusali, et al.
  Pubblicazione: (2024)